Navigation Links
Death from heart attack can be reduced by new drug combination

Heart attack remains one of the significant causes for mortality in more than 10 million people all over the world. It accounts for 29.2 percent of total global deaths according to the World Health Organization.// People who survive the episode require long-term care and support. Amongst the risk factors, the important ones are obesity, smoking, diabetes, high blood pressure and high cholesterol.

A majority of the deaths can now be prevented by a combination of aspirin and another drug Clopidogrel. The drug combination has been found to be very effective in preventing the clot formation in such patients.

Aspirin is a standard emergency treatment given to heart attack patients and the proposed drug (Clopidogrel) is the world's fourth biggest-selling drug. If the clopidogrel therapy was instituted to just 1 million people then more than 10000 deaths, non-fatal repeat heart attacks and stroke could be prevented.

The efficacy of the drug has been studied in a group of 45,800 patients against a placebo and patients who received 75 milligrams of the drug daily, in addition to an aspirin or other treatment for 4 weeks, had a 7 % and 14 % reduction in death rate and repeat heart attack rate respectively.

The researchers also found that using the blood pressure drug metoprolol intravenously and then orally as an emergency treatment for heart attacks reduced the relative risk of a repeat attack but raised the odds of cardiac shock, especially in the first day or so after being admitted to hospital.

The drug is complementary to aspirin but works in a different way. Only about two weeks of treatment with the drug would be needed so the costs would be small. The safety and the efficacy of the drug have also been satisfactory. Hence it has been suggested that the drug be used routinely on top of aspirin to produce a moderate yet significant health benefit in the emergency treatment of heart attack.


'"/>




Page: 1

Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Risk Higher in Obese Women with Colon Cancer
9. Death Among the Homeless
10. Diabetes on the Increase but Death Rate Falling
11. Drug Users and Risk of Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: